The Immunology of Psoriasis-Current Concepts in Pathogenesis
Open accessThe DOI matches its Crossref record; 308 of the 308 references it cites were found in a registry or an index.
Abstract
Psoriasis is one of the most common inflammatory skin diseases with a chronic, relapsing-remitting course. The last decades of intense research uncovered a pathological network of interactions between immune cells and other types of cells in the pathogenesis of psoriasis. Emerging evidence indicates that dendritic cells, T H 17 cells, and keratinocytes constitute a pathogenic triad in psoriasis. Dendritic cells produce TNF-α and IL-23 to promote T cell differentiation toward T H 17 cells that produce key psoriatic cytokines IL-17, IFN-γ, and IL-22. Their activity results in skin inflammation and activation and hyperproliferation of keratinocytes. In addition, other cells and signaling pathways are implicated in the pathogenesis of psoriasis, including T H 9 cells, T H 22 cells, CD8 + cytotoxic cells, neutrophils, γδ T cells, and cytokines and chemokines secreted by them. New insights from high-throughput analysis of lesional skin identified novel signaling pathways and cell populations involved in the pathogenesis. These studies not only expanded our knowledge about the mechanisms of immune response and the pathogenesis of psoriasis but also resulted in a revolution in the clinical management of patients with psoriasis. Thus, understanding the mechanisms of immune response in psoriatic inflammation is crucial for further studies, the development of novel therapeutic strategies, and the clinical management of psoriasis patients. The aim of the review was to comprehensively present the dysregulation of immune response in psoriasis with an emphasis on recent findings. Here, we described the role of immune cells, including T cells, B cells, dendritic cells, neutrophils, monocytes, mast cells, and innate lymphoid cells (ILCs), as well as non-immune cells, including keratinocytes, fibroblasts, endothelial cells, and platelets in the initiation, development, and progression of psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most frequent and important findings are represented by the psoriasiform pattern associated with confluent parakeratosis and chronic dermal inflammation.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dilated and tortuous capillaries are frequently present in the papillary dermis and correspond clinically to the Auspitz phenomenon [20].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The disease is characterized by hyperproliferation of the epidermis, with a high epidermal turnover rate and scale formation.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Neutrophilic collections represent important diagnostic clues.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fully developed plaques typically demonstrate regular acanthosis with elongated and relatively uniform rete ridges, thinning of the suprapapillary plates, confluent parakeratosis, and reduction or absence of the granular layer.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measured
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 2×
“However, IL-17 is also implicated in a variety of T H 17-mediated inflammatory autoimmune diseases [113, 114].”
BackgroundIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review
Armstrong, A. W., & Read, C. (2020) · JAMA · doi:10.1001/jama.2020.4006 · Cited by 2,335
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 2×
“It was demonstrated that IL-17 and IL-22 can be co-expressed by T H 17 cells and synergize in the induction of the expression of AMPs by KCs in vitro [208].”
BackgroundPsoriasis Pathogenesis and Treatment
Rendon, A., & Schäkel, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061475 · Cited by 2,064
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · cited 3×
“Complexes consisting of DNA or RNA and LL37 are abundant in lesional skin [19, 106].”
BackgroundInterleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862 · cited 1×
“IL-22 produced by T H 22 cells mediates acanthosis and immune cell infiltration induced by IL-23 [69].”
BackgroundAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847 · cited 3×
“T H 17 cells are activated by factors that are upregulated in the psoriatic milieu, including IL-23, as well as IL-21 in an autocrine manner [68, 74].”
Background
Cited by
Items 101–200 of 346
Mo, W., Zhang, Y., Zeng, Y., Zheng, Y., Zhao, S., Wang, X., & Fan, X. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103959 · Cited by 4
Ding, J., Sun, A., Hu, H., Li, J., Lu, S., Song, J., He, J., Song, X., Qian, S., & Tian, Z. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s563272 · Cited by 4
“31 TLR-mediated activation of keratinocytes, pDC and/or cDC initiates early innate immune events, which is related to T cell activation and the development of autoimmunity in psoriasis.”
Huang‐Ping, Y., Yang, S.-C., Lin, C.-Y., Alalaiwe, A. S., Yang, H.-Y., & Fang, J. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05986-1 · Cited by 4
“It has been demon - strated that > 80% of the genes whose expression is upregulated in psoriatic lesions are involved in the stimulation of keratinocytes and macrophages [57].”
InfluentialGiraulo, C., Palma, G. D., Plaitano, P., Esposito, R., Morretta, E., Monti, M. C., Müller, C. E., Cicala, C., & Morello, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1698290 · Cited by 3
“…— including T cells, dendritic cells, neutrophils, monocytes and macrophages — elevated levels of proin fl ammatory mediators such as tumor necrosis factor (TNF)- a , interleukin (IL)-12, IL-22, IL-23, IL-17, and chemokines, and increased neoangiogenesis with high levels of growth factors (1, 2).”
Vos, S. D., Desroy, N., Bellaire, S., Fernandes, A. P., Lavazais, S., Merciris, D., Delachaume, C., Robin-Jagerschmidt, C., Cosson, A., Lazaryan, A., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.171776 · Cited by 4
“Concomitant induction of IL-10 by myeloid cells and Bregs may promote immune tolerance through Treg expansion and inhibition of Th17 responses (65–67).”
Immunogenetics in psoriasis: towards personalised diagnosis and treatment strategies
Sugumaran, D., Yong, A. C. H., How, K. N., & Stanslas, J. (2026) · Genes and Immunity · doi:10.1038/s41435-026-00402-5 · Cited by 3
“Autoimmune disorders, such as psoriasis, are triggered by an imbalance in the immune system [66].”
Zhang, Y., Guo, D., Zhou, Y., Wang, C., Su, G., Huang, J., Wan, Y., Zhang, H., Wan, H., Bo, L., et al. (2026) · Biomarker Research · doi:10.1186/s40364-026-00948-6 · Cited by 6
“By activating the STAT3 signaling pathway, IL-23 potently drives the differentiation of naïve CD4 + T cells into the Th17 lineage [93], which subsequently produce large amounts of IL-17A, IL-17F, and IL-22, thereby initiating a cascade of cutaneous inflammation [51, 53].”
Zhan, Q., Wang, P., Li, Z., Shen, Z., Xu, J., Liu, M., Bai, Q., Deng, S., Sheng, Y., 姜啸然, et al. (2026) · British Journal of Dermatology · doi:10.1093/bjd/ljag314 · Cited by 3
Priyadarshinee, A., Amulya, E., Vambhurkar, G. B., Jain, A., Puri, N., Sahane, P., & Srivastava, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143089 · Cited by 5
Luo, G., Kong, X., Wang, F., Wang, Z., Zhang, Z., Cui, H., Zhang, Y., Huang, W., Yang, X., & Ye, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1585369 · Cited by 3
“Previous research has primarily focused on the pathogenesis of the individual conditions, making it challenging to understand their interactions (Sieminska et al., 2024).”
Chung, H. S., & Hwang, H. S. (2025) · Food Science and Biotechnology · doi:10.1007/s10068-025-01894-z · Cited by 5
“When inflammatory cytokines, such as TNF-α, IL-17 A, IL-22, and IFN-γ, secreted by differentiated Th1, Th2, and Th17 cells, are released into the dermis, they also have a significant impact on keratinocytes in the adjacent epidermal layer (Grän et al., 2020; Sieminska et al., 2024).”
Human epidermis models demonstrate mediator role of TLR2 and TLR3 for psoriatic inflammation
Glasebach, H., Denzinger, L., Rupp, S., & Burger‐Kentischer, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1663279 · Cited by 3
“One common attribute of all of these factors is the activation of pathogen recognition receptors (PRR) such as Toll-like receptors (TLR) (8).”
Cheng, C., Wang, Y., Huo, J., Zhang, Y., & Li, R. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113932 · Cited by 3
Association between psoriasis and gut microbiota: a review
Vasilyeva, V. P., Yenina, D. S., Kapustina, E., Kapko, A. V., Cherkasova, A. A., & Raevskii, K. P. (2025) · Russian Medicine · doi:10.17816/medjrf643065 · Cited by 2
Fratton, Z., Stinco, G., & Errichetti, E. (2025) · Pediatric Dermatology · doi:10.1111/pde.15965 · Cited by 2
The global patent landscape of devices for psoriasis diagnosis and treatment
Xu, C., Zhang, T., Zhang, J., Tan, F., Tai, Z., & Chen, Z. (2025) · World Patent Information · doi:10.1016/j.wpi.2025.102375 · Cited by 2
Zhou, P., Jiang, X. M., Wang, W., & Wang, D. (2025) · Human Immunology · doi:10.1016/j.humimm.2025.111565 · Cited by 4
Demetrius, D., Perez, S. M., Suzuki, T., Gherardini, J., Lee, W., Chéret, J., & Paus, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167811 · Cited by 2
“…elevated levels of IFN γ promote the recruitment and activation of M1 MACs [10,20], it is less well-understood how IFN γ impacts immunoinhibitory M2 MACs in human skin, and how IFN γ interacts with other presumably pro-inflammatory cytokines found in chronic immunodermatoses such as IL-15 [21,22].”
Chen, X., Zeng, T., Fang, F., Tian, Q., Li, Y., Zhou, W., Gong, B., Tian, N., Zhang, J., & Xiao, Y. (2025) · AMB Express · doi:10.1186/s13568-025-01931-4 · Cited by 3
“Research indicates that psoriasis is regulated by intricate connections between external cytokine pathways and intracellular signaling molecules (Sieminska et al. 2024).”
Mastrangelo, M., Ruscitti, P., Bruni, M., Lucantonio, E., Berardinis, A. D., Barile, A., Fargnoli, M. C., Cipriani, P., Esposito, M., & Pellegrini, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1672667 · Cited by 2
“The idea of the psoriatic disease continuum is increasingly prompted by multiple lines of evidence proposing a spectrum of in fl ammatory manifestations ranging from cutaneous to joint features according to a shared pathogenesis (4, 5, 8, 23).”
Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy
Lee, H. J., So, Y. J., Jo, I., Jang, J. Y., Yook, T. H., Lee, J. H., Kim, S. W., Lee, K., Park, S.-J., & Yang, G. (2025) · Phytotherapy Research · doi:10.1002/ptr.70085 · Cited by 2
Garg, A., Chauhan, C., & Deshmukh, R. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10166-6 · Cited by 2
“Approximately 40% of patients have a family member with psoriasis or psoriatic arthritis [ 14, 15].”
Dayem, A. A., Song, M., Park, J., Jeong, K., Lim, K. M., Kim, S., Song, K., & Cho, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110297 · Cited by 3
“Psoriasis is not a disease confined to the hyperactivation of a single cytokine or cellular pathway; instead, its pathogenesis involves complex interactions among various immune cells, including Th1/Th17 cells, DCs, macrophages, and KCs [210].”
Yue, H., Mo, H., Su, H., Zeng, Z., Liu, F., Lei, C., Sun, Y., Wang, T., Pi, X., Li, L., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s560634 · Cited by 2
Characteristics of peripheral blood lymphocyte subsets in elderly patients with psoriasis
Liu, R., Zhao, J., Gao, Q., & Kuang, Y. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00540-w · Cited by 2
“While the pathogenesis involves well-established inflammatory pathways mediated by T helper 17 (Th17) cells, interleukin (IL)−17, and IL-23, the intersection of psoriasis with age-related immune changes remains poorly understood [3] [4].”
Research progress of biomaterial-based hydrogels in the treatment of psoriasis
Xiao, L., Kuang, X., Zhang, T., Tang, Y., Wu, J., & Zheng, Y. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126353 · Cited by 5
Lights and Shadows of Nutrient-Driven Keratinocyte Inflammation in Psoriasis
Speranza, D., Pantano, A., Cullotta, C., Pallio, G., Vaccaro, M., Scuruchi, M., & Irrera, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311652 · Cited by 4
“…integral components of the innate immune system, KCs respond to initial triggers and pro-inflammatory signals by releasing antimicrobial peptides, including S100 alarmins (S100A7, S100A8, S100A9), hBD2, and self-nucleotides [13], which promote the activation of plasmacytoid dendritic cells (pDCs).”
Huang, Z., Wang, Y.-Y., Xiao, Y. L., Yang, J., Wan, W.-G., Huang, P., Guo, Q., Zou, H.-J., & Yang, X. (2025) · ACS Omega · doi:10.1021/acsomega.5c07963 · Cited by 2
Lin, J., Su, Z., Zeng, Y., Zhou, Y., Zeng, C., Zhang, W., Li, Q., Xiao, Z., Chen, Z., Liu, Z., et al. (2026) · Advanced Science · doi:10.1002/advs.202520617 · Cited by 3
“Emerging evidence has shown that disease-specific fibroblast subpopulations aggravate local inflammation by recruiting and regulating the functions of neutrophils [ 11, 12 ].”
Topical ionic liquid-mediated GLUT1 gene editing ameliorates psoriasis and prevents recurrence
Yin, B., Wu, X., Zhou, H., Yu, M., Liu, J., Ding, L., Zhu, C., Tai, Z., Zhu, Q., & Chen, Z. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124058 · Cited by 2
Assessing Targeted Proteomics in Inflammatory Skin Diseases with the Tape-stripping Method
Vinge, A. S., Altintas, S., Ødum, N., Johansen, J. D., Løvendorf, M. B., & Skov, P. L. (2026) · Acta Dermato Venereologica · doi:10.2340/actadv.v106.43362 · Cited by 2
“…applied in this study enabled detectabi-lity of many key inflammatory biomarkers in psoriasis including IFN-γ, TNF, IL-6, IL-8, IL-12B, IL-17A, IL-17C, and CXCL10 (10, 31) and concentrations for these proteins were all significantly higher in lesional psoriasis skin compared with healthy skin.”
Yıldırım, S. K., Ayyıldız, S., Öğüt, N. D., Erbağcı, E., Ünal, S., & Gökyayla, E. (2026) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s589513 · Cited by 2
“8–10 Among clinical parameters influencing the achievement of a PASI 90 response at month 6 with biologic therapy, prior biologic exposure, older age, higher body mass index, and current or past smoking have been identified as negative predictors of treatment outcomes.”
Vahav, I., Thon, M., Koning, J. J., Gibbs, S., Thiel, A., & Loyal, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1790531 · Cited by 3
Immune cells in keloids: mechanisms and potential treatments
Wu, Y., Huang, Y., Zhang, H., Dong, C., & Chen, X. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2655499 · Cited by 3
“Following cutaneous injury, various immune cell populations, such as neutrophils, macrophages, DCs, NK cells, and CD8 + T lymphocytes—are promptly activated and secrete a range of cytokines and chemokines [24,25].”
Czarnowicki, T., Sugita, K., Yiu, Z. Z. N., Díez-Ribas, S., García‐Jiménez, I., Guttman‐Yassky, E., & Santamaria‐Babí, L. F. (2026) · Allergy · doi:10.1111/all.70347 · Cited by 2
“In psoriasis, innate immune cells such as dendritic cells (DCs), neutrophils, and keratinocytes initiate inflammation by releasing cytokines such as TNF-α, IL-17, and IL-23 [61].”
Yi, X., Yu, P., Wang, J., Fang, C., Ma, S., Li, K., Yan, R., Wang, G., Chen, Y., Chen, C., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01717-z · Cited by 2
Ma, J., Li, H., Yang, X., Cheng, Y. F., Qi, B., Kang, S., Qi, H., Qi, R., & Niu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1830099 · Cited by 5
“Additional immune populations, including Th22 cells, Th9 cells, and innate lymphoid cells, also contribute to psoriatic in fl ammation, underscoring the complexity of the broader in fl am-matory network underlying disease pathogenesis (28).”
Lewandowska, J. A., & Owczarczyk-Saczonek, A. B. (2026) · Dermatology and Therapy · doi:10.1007/s13555-026-01733-x · Cited by 2
“…secreted mainly by T cells, such as interleukin (IL)–17, IL–21, IL–22, and interferon (IFN)– γ , as well as by dendritic cells (DCs), notably tumor necrosis factor (TNF)– α , IL–6, IL–20, IL–23, nitric oxide, and KCs themselves, including antimicrobial peptides (AMPs), IL–20, and chemokines [11].”
Liu, Q., Wu, Y., Tang, J., & Kuang, Y. (2026) · Experimental Dermatology · doi:10.1111/exd.70275 · Cited by 3
“…macrophage-derived IL-23, IL-1β and TNF-α drive Th17/γδT17 cells to produce IL-17, which in turn stimulates keratinocyte hyperglycolysis, proliferation and inflammatory cytokine secretion, thereby establishing a positive feedback loop involving macrophages, Th17 cells and keratinocytes [14].”
Zhao, L., Chen, Z., Sun, Y., Jia, K., Liu, Y., & Li, P. (2026) · Nutrients · doi:10.3390/nu18121838 · Cited by 2
“In psoriasis, this is particularly pertinent because the disease is strongly associated with IL-23/IL-17-dominant circuitry, whereas in AD the inflammatory architecture is canonically more Th2-polarized, albeit with important subtype-and stage-dependent variation [35].”
Jin, L., Pei, S., Dong, L., Li, X., Kuang, Y., Zhu, W., Chen, X., & Yin, M. (2026) · Journal of Autoimmunity · doi:10.1016/j.jaut.2026.103610 · Cited by 2
Toledo, M. D. G. T., Lazo, R. E. L., Domingos, E. L., Zein, A. K. E., Cobre, A. D. F., Borba, H. H. L., Ferreira, L. M., & Pontarolo, R. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106275 · Cited by 5
Lin, Y., Zhao, X., Yang, Z., Dongfang, Z., Zeng, Y., Du, C., Jiang, L., Yin, X., Xiao, J., Hu, C., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119680 · Cited by 2
Small molecular inhibitors targeting Janus kinases (JAKs) for the treatment of psoriasis
Zhang, D., Miao, X., Liu, P., Liu, H., Li, C., Liu, Y., & Sun, Y. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117904 · Cited by 4
Radu, A.-F., Jurca, T., Radu, A.-F., Bodog, T. M., Bodog, R. F., & Endres, L. M. (2025) · Life · doi:10.3390/life15081186 · Cited by 2
“The disease can severely impact a person’s quality of life, as many affected individuals experience not only physical discomfort but also significant emotional and social distress [1,2].”
Hao, L.-H., Zhang, Y., Sun, Y., Han, Y., Ye, J., Wang, H., Gao, L., Wang, D., Gao, Y. L., Yang, Y., et al. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111597 · Cited by 7
Tinca, A. C., Cozac-Szoke, A. R., & Cotoi, O. S. (2026) · Dermatopathology · doi:10.3390/dermatopathology13020022 · Cited by 1
“The other characteristics mentioned are not always seen [20,21].”
InfluentialStaniszewska, I. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.73.51552 · Cited by 1
Ojha, M., Manocha, N., Kumar, V., Karthikeyan, G., & Toor, D. (2025) · Pharmaceuticals · doi:10.3390/ph18030304 · Cited by 1
“…pivotal role in psoriasis, with cytokines such as tumour necrosis factor alpha (TNF-α ), interleukin (IL) -6, IL-8, IL-17, IL-22, IL-23, and RANTES (Regulated upon activation, normal T Cell expressed and presumably secreted) being central to the inflammatory processes observed in the disease [4,5].”
Han, L., Lin, G., Lv, X., Han, B., Xu, X., Li, S., Li, S., Chen, D., Huang, Z., Gu, G., et al. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.107018 · Cited by 1
“Psoriasis is caused by changes in skin barrier function and dysregulation of skin immune response, and its pathogenesis involves genetic susceptibility, environmental factors, and immune dysregulation [6, 8] .”
Pathophysiological roles of innate immune cells in psoriasis
Kim, D. H., & Jung, J. M. (2025) · Daehan geonseon hakoeji (Online) · doi:10.23203/jksp.2025.22.1.13 · Cited by 1
Protein targets & therapeutics in psoriasis: toward personalization
Shaikh, M. A., Haque, Z., Haque, A., Kumar, S., & Taleuzzaman, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115331 · Cited by 2
Favaro, R., Facheris, P., Formai, A., Gargiulo, L., Ibba, L., Fiorillo, G., Latorre, R. V., Avagliano, J., Narcisi, A., Girolomoni, G., et al. (2025) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2025.08.002 · Cited by 1
Multifaceted Roles of Dermal Fibroblasts in Skin Health and Disease
Galati, A., Gallo, R. L., & Cavagnero, K. J. (2025) · Dermatologic Surgery · doi:10.1097/dss.0000000000004668 · Cited by 2
Zhang, C., Chi, H., Pang, X., Liu, J., Sun, B., & Zhang, M. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503942 · Cited by 1
Abdelrahman, H. W., Kadry, S. M., Morsy, W. A., & Hassen, M. G. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04811-7 · Cited by 1
“The synthesis of several proinflammatory cytokines is triggered by IL-17A and other inflammatory factors acting on keratinocytes, which further leads to a direct influx of immune cells to the site of IMQ administration and amplifies skin inflammation (Sieminska et al. 2024).”
Cell population data as predictive biomarkers for biologic therapy response in psoriasis
Liu, R., Zuo, C., Zhao, J., Xie, T., Qi, K., Gao, Q., & Kuang, Y. (2025) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2025.2604057 · Cited by 1
“A recent systematic review emphasized the central role of immune cell activation in psoriasis pathogenesis [29].”
Xia, K., Tan, Z., Tang, X., Chen, M., Deng, Z., Li, J., Luo, H., Dong, J., Zhu, Y., Xu, S., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.153208 · Cited by 1
Cho, Y., Oh, Y., Park, J., Kwon, J., & Kim, T. S. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178564 · Cited by 1
Siriyong, T., Anuntrangsee, W., Kaewtan, J., Chartleeraha, S., Khaonim, K., Manee, W., Ontong, J. C., & Voravuthikunchai, S. P. (2026) · Current Traditional Medicine · doi:10.2174/0122150838421275251128081230 · Cited by 1
Cross-disease analysis identifies the inflammatome as a transcriptional program of inflammation
Cort, I. D., Palasca, O., Gaessler, L. F., Jakobsen, T. H., Bjarnsholt, T., & Jensen, L. J. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116883 · Cited by 2
Liu, Y., Wong, V. K. W., Liu, J., Jiang, M., Yang, C., He, X., Wang, J., Zhang, L., Xiong, A., Ran, Q., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1754729 · Cited by 1
“Th17 effector cytokines, including IL-17A, IL-17F, IL-21, IL-22, and TNF-α , further activate keratinocytes, leading to the production of chemokines, antimicrobial peptides, and enhanced proliferation, thereby sustaining a pathogenic inflammatory loop (Li et al., 2020; Sieminska et al., 2024).”
Novel Systemic Associations of Idiopathic Epiretinal Membrane Identified via Machine Learning
Wu, E., Jiang, J. Y., Hasan, N., Du, K., Zhang, M., Yao, J., Vupparaboina, K. K., Bollepalli, S. C., Sahel, J., & Chhablani, J. K. (2026) · Ophthalmology Science · doi:10.1016/j.xops.2026.101124 · Cited by 1
“20,21 This raises the possibility that systemic inflammatory pathways, rather than local retinal pathology alone, may contribute to ERM formation in certain patient populations.”
Vasarri, M., Degl’Innocenti, D., Lulli, M., Schiavone, N., Verdelli, A., Caproni, M., Antiga, E., & Barletta, E. (2026) · Marine Drugs · doi:10.3390/md24020085 · Cited by 2
Han, Y., Ren, J., Su, Y. K., Zhou, L., Zhu, X., Wang, Z., Kong, F., & Li, G. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04264-x · Cited by 1
“Epidermal hyperplasia, dilated and conspicuous blood vessels (primarily within the dermis), and abnormal keratinocyte proliferation are the three main histological hallmarks of psoriasis [2, 27].”
InfluentialSIRT1-mediated regulation of inflammation and keratinocyte function in psoriasis
Shafi, A., Khan, M. N., & Gulati, P. (2026) · Gene Reports · doi:10.1016/j.genrep.2026.102476 · Cited by 1
Balogh, B., Klusóczki, Á., Pető, Á., Fehér, P. S., Ujhelyi, Z., Váradi, J., & Bácskay, I. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107510 · Cited by 1
Sia, J., Lee, B., & Oon, H. H. B. (2026) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-026-09152-8 · Cited by 2
Noor, A. A. M., Lambuk, L., Ahmad, F., Azlan, M., & Redzwan, N. M. (2026) · PeerJ · doi:10.7717/peerj.20974 · Cited by 1
“Broader reviews also highlight that while IL-23-producing DCs are recognized as pivotal drivers of the psoriatic loop, the interplay between DCs, B cells and other immune cells remains insufficiently mapped ( Sieminska, Pieniawska & Grzywa, 2024 ).”
Genetic Association Study of IL23R and IL12B Polymorphisms with Psoriasis in a Romanian Population
Matei-Man, A.-M., Gaal, O. I., Catana, A., Vesa, Ș. C., Șenilă, S. C., Candrea, E., Orăsan, M. S., Pușcaș, A. D., Man, A. C., & Mocan, T. (2026) · Life · doi:10.3390/life16040574 · Cited by 1
“Despite their high efficacy, considerable interindividual variability in treatment response persists, suggesting that genetic determinants may partly explain differences in therapeutic outcomes [10,12].”
Cheng, B., Zhang, Z., Bai, R., Du, W., Le, H., He, K., Yin, T., Wang, Z., Liu, X., Liu, J., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.03.061 · Cited by 1
Chen, Q., Ma, Y., Liu, Y., Wang, X., Huang, G., Yang, Y., Ko, J. K.-S., & Chen, H. (2026) · Biomedicines · doi:10.3390/biomedicines14040850 · Cited by 3
Alox8 knockout exacerbates imiquimod-induced psoriasis-like inflammation
Palmer, M. A., Kirchhoff, R., Hahnefeld, L., Thomas, D., Elewa, M. A. F., You, X., Aliraj, B., Benatzy, Y., Weigert, A., Schebb, N. H., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08727-9 · Cited by 1
“It is pathologically driven by in fi ltration of immune cells, leading to interleukin (IL)-23/Th17 signalling axis, hyperproliferation, and abnormal differentiation of keratinocytes [10].”
Upadacitinib is effective in treating psoriasis combined with lichen planus: a case report
Li, X., Qi, J., Shi, L., Liu, L., Xie, X., Zhang, G., & Zhu, Q. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1771710 · Cited by 1
“The signaling of these cytokines is mediated, to varying degrees, by the JAK-STAT pathway (13).”
Amoia, P., Gallorini, M., Scarponi, C., Franco-Montalbán, F., Bonfanti, P., Colombo, A., Francesco, V. D., Madonna, S., Ammazzalorso, A., Filippis, B. D., et al. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00683 · Cited by 1
Han, K. K., Klein, R. J., Recupero, T. C., Russo, A. C., Sharma, R., Gupta, A. K., Hassanzadeh, S., Huffstutler, R. D., Dagur, P. K., Fisk, B., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.203826 · Cited by 2
“Psoriatic inflammation arises in par from dysregulated signaling among dermal innate, adaptive, and nonprofessional immune cells (21).”
γδ T Cell-Mediated Neuroimmune Interactions in Skin Inflammation and Allergy
Peng, S., & Honda, T. (2026) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-026-09168-0 · Cited by 1
Drug-induced psoriasis following sacubitril/valsartan: a case report and literature review
Tang, T., Guo, M., Yu, H., Zhang, Y., Lei, S., Li, S., Chen, W., & Lou, Y. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06004-3 · Cited by 1
“Genetic predisposition, immune dysregulation, and environmental factors play a critical role in the pathogenesis of psoriasis [4, 11].”
Filipek, K., Nowowiejska, J., & Flisiak, I. (2026) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s598115 · Cited by 4
“12 The chronic inflammatory condition in psoriasis is not only limited to the local skin inflammation, but rather systemic, which may account for the higher risk of comorbidities such as cardiovascular disease, obesity, metabolic syndrome, and others, in which the inflammatory background is also…”
InfluentialWang, W., Liu, T., Wang, X., Dong, Z., Yang, J., He, X., Dong, J., Wang, H., Wang, Y., Dong, R., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117372 · Cited by 1
Bu, T., Gong, Z., Ma, Y., Dai, L., Yh, M., Yu, X., Yang, X., 苗小楼, & Shang, X. (2026) · Biomolecules · doi:10.3390/biom16060802 · Cited by 1
Involvement of the external ear by inflammatory skin diseases
Chiriac, A. E., Pinteală, T., Chiriac, A., & Wollina, U. (2026) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2026.05.013 · Cited by 1
Vunakizumab for IL-17A–Mediated Diseases: A Review in Psoriasis and Spondyloarthritis
Yan, H., Chen, Y., Song, Y., Yan, M., & Yan, K. (2026) · Biologics · doi:10.2147/btt.s500475 · Cited by 1
“30 Upon binding to the IL-17RA/RC receptor complex, IL-17A recruits ACT1 and activates NF-κB and MAPK signaling pathways, inducing pro-inflammatory cytokines, chemokines, and antimicrobial peptides.”
Cong, R., Zhou, S., Li, L., Li, F., Ren, J., Zhu, Q., Yang, H., Tu, J., Jiang, X., & Jiang, L. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c09469 · Cited by 1
A light-controlled hydrogel for regulating oxidative stress in the treatment of psoriasis
Shi, J., Li, X., Mao, Y., Ling, G., & Zhang, P. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127134 · Cited by 1
Skin barrier dysfunction and correlation with the onset and progression of psoriasis
Wang, Y., Liang, Y., Xing, J., Li, J., & Zhang, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1808904 · Cited by 4
Mohanty, S., Panda, P., & Mohapatra, R. (2026) · Immunotherapy · doi:10.1080/1750743x.2026.2697682 · Cited by 1
Pillai, V., & Rasool, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1817338 · Cited by 1
Luo, Q., Shi, R., Yang, D., Tang, Y., Xie, Q., Shi, Y., & Sun, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1856647 · Cited by 1
Self-antigen keratin 17 presented by keratinocytes promotes T-cell autoreactivity in psoriasis
Xiao, C., Hao, J., Guo, Y. X., Ma, Y., Bai, Y., Zhang, C., Li, K., Luo, Y., Wang, G., & Dang, E. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2026.07.009 · Cited by 1
Drug-associated psoriasis: a pharmacovigilance study based on the FAERS database
Yi, S., Liu, A., Huoshen, W., 夏登梅, & Ma, X. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1888496 · Cited by 1
Ghosh, U., & Tay, A. K. P. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115204 · Cited by 1
Bonilha, C. S. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103813 · Cited by 4
Łętocha, A., Miastkowska, M. A., & Sikora, E. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156763 · Cited by 2
“These cells enter the circulation and gain the capacity to home to the skin [101,102].”
Haghpanah, A., Alvandi, H., Ansari, E., Hatamian-Zarmi, A., Ghandi, N., & Mokhtari‐Hosseini, Z. B. (2026) · Materials Today Communications · doi:10.1016/j.mtcomm.2026.115837 · Cited by 1
Inflammatory Biomarkers for Assessing Treatment Response in Psoriasis: A Narrative Review
Lewandowska, J. A., Owczarczyk-Saczonek, A. B., & Nedoszytko, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167221 · Cited by 1
“…count (CBC)-derived indices (e.g., neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and systemic immune-inflammation index (SII)), C-reactive protein (CRP), and other circulating cytokines, contributing to cardiometabolic risks [3–7].”
Li, Y., Sun, W., Jin, X., Li, L., Zhang, X., Fan, P., Huang, Y., Xiong, C., Wang, J., Wei, J., et al. (2026) · MedComm · doi:10.1002/mco2.70960 · Cited by 1
“Dysregulated activation of the IL-23/IL-17 axis initiates a self-amplifying inflammatory cascade that is critical for psoriasis pathogenesis [ 58, 59 ].”
Innovative Small-molecule Therapies for Psoriasis
Köhler, I. (2024) · Linköping University medical dissertations · doi:10.3384/9789180758390 · Cited by 1
Phytotherapeutic advances in psoriasis: A natural approach to treatment
Mahveen, S. H., Rimsha, R., Maheen, S. R., & Saeed, F. U. (2025) · Journal of Phytonanotechnology and Pharmaceutical Sciences · doi:10.54085/jpps.2025.5.1.4 · Cited by 1
Umbilical Cord Mesenchymal Stem Cells as a Meritorious Option to Treat Psoriasis
Arefnezhad, R., Jahani, S., Alipour, A., Amini, D. A., Safarpour, M. M., Jahangiri, S., Rouzbahani, A. K., Zarei, H., & Rezaei‐Tazangi, F. (2025) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x382147250801101300 · Cited by 1
Metadata
- Authors
- Sieminska, I., Pieniawska, M., & Grzywa, T. M.
- Affiliations
- Institute of Human Genetics (PL)
- Children's Hospital of Philadelphia (US)
- Corresponding author
- Grzywa, Tomasz M.
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2024-04-20
- Volume
- 66
- Issue
- 2
- Pages
- 164-191
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- PMC
- PMC11193704
- OpenAlex
- W4394989398
- Semantic Scholar
- 7834ce05fae760dae63e391276786d133a044e08
- Cited by
- 346
- References
- 308
- Citations by year
- 2026: 187 · 2025: 140 · 2024: 19
- FWCI
- 15.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Clinical Reviews in Allergy & Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Narodowe Centrum Nauki (2021/41/N/NZ6/02774)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- psoriasis, psoriasis pathogenesis, dendritic cells, Th17 cells, keratinocytes, IL-23, TNF-α, IL-17, IL-22, Th9 cells, Th22 cells, cytotoxic T lymphocytes, neutrophils, γδ T cells, innate lymphoid cells, mast cells, non-immune cells, skin inflammation, immune dysregulation
- MeSH terms
- Animals, Dendritic Cells, Humans, Psoriasis, Skin, Signal Transduction, Keratinocytes, T-Lymphocyte Subsets, Cytokines, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.